HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 1, 2009, Pages 45-50

  Grigorescu, Mircea ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Chronic hepatitis; Epidemic profile; Genotypes; Hepatitis C virus; Romania

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BODY PIERCING; FEMALE; GENERAL SURGERY; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS VIRUS TRANSMISSION; PREVALENCE; RISK FACTOR; ROMANIA; TATTOO; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHILD; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; HUNGARY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOLDOVA; PREVALENCE; RNA, VIRAL; ROMANIA; TRANSAMINASES; VIRAL LOAD; YOUNG ADULT;

EID: 70549106865     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect 2002; 4: 1219-1225.
2. The Global Burden Of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44: 20-29.
3. Dehesa-Violante M, Nuñez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007; 38: 606-611.
4. Wasley A, Alter M. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16. (Pubitemid 30421405)
5. World Health Organization. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 1999; 74: 425-427.
6. World Health Organization. Global distribution of hepatitis A, B and C 2001. Wkly Epidemiol Rec 2002; 77: 45-47.
7. Grigorescu M, Radu C, Pascu O, et al. Etiological profile of chronic hepatitis and liver cirrhosis in Romania. A multicenter study. Rom J Gastroenterol 2001; 10: 199-204. (Pubitemid 32911891)
8. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.. J Gen Virol 1993; 74: 2391-2399. (Pubitemid 23332300)
9. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. J Hepatol 1999; 31(suppl 1): 3-8.
10. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. Hepatology 2002; 36(5 Suppl 1): S3-S20. (Pubitemid 35253459)
11. Zeuzem S, Yoshida EM, Benhamou Y, et al. Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C. Hepatology 2008; 48: 407-417.
12. Bedossa P. Présentation d'une grille d'analyse informatisée pour le recueil des lesions histopthologiques dans l'hépatite chronique virale C. Étude Cooperative des Groupe METAVIR. Ann Pathol 1993; 13: 260-265. (Pubitemid 23334027)
13. Bouchardeau F, Cantaloube JF, Chevaliez S, et al. Improvement of hepatitis C virus (HCV) genotype determination with a new version of the INNO-LiPA HCV assay. J Clin Microbiol 2007; 45: 1140-1145. (Pubitemid 46626476)
14. Streinu Cercel A, Colţan G, Neamţu A, et al. Hepatitis C genotyping in Romania [in Romanian]. Med Update 1999 (Mars): 133-135.
15. Chen J, McGuinness PH, Koorey DJ, Rickard K, Wylie B, McCaughan GW. Hepatitis C virus genotypes in a cohort of Australian blood donors and haemophiliac and liver transplant patients. J Gastroenterol Hepatol 1997; 12: 182-187. (Pubitemid 27096393)
16. Dusheiko G, Schmilowitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: an investigation of type specific differences in geographic origin and disease. Hepatology 1994; 19: 13-18. (Pubitemid 24020465)
17. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 1995; 122: 161-168.
18. Svirtlih N, Delic D, Simonovic J, et al. Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J Gastroenterol 2007; 13: 355-360. (Pubitemid 46178968)
19. Nainan OV, Alter MJ, Kruszon-Moran D, et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology 2006; 131: 478-484. (Pubitemid 44142463)
20. Kato N, Yokosuka O, Hosoda K, et al. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20. (Pubitemid 23193611)
21. Fattovich G, Ribero ML, Pantalena M, et al. Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen in tertiary referral centres in Europe. J Viral Hepat 2001; 8: 206-216. (Pubitemid 32506634)
22. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125: 634-639. (Pubitemid 126450598)
23. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 2001; 64: 350-355. (Pubitemid 32565132)
24. Zeuzem S, Buti M, Ferenci P, et al. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepatol 2006; 44: 97-103. (Pubitemid 41772522)
25. Jensen DM, Morgan TR, Marcellin P et al. Early indentification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40kd)/ribavirin therapy. Hepatology 2006; 43: 954-960. (Pubitemid 43724620)
26. Mangia A, Minerva N, Bacca D, et al. Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial. Hepatology 2008; 47: 43-50. (Pubitemid 351171040)
27. Pradat P, Alberti A, Poynard T, et al. Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology 2002; 36: 973-977.
28. Viazov S, Kuzin S, Paladi N, et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 1997; 53: 36-40. (Pubitemid 27395893)
29. Gervain J, Simon Jr G, Simon J; Hungarian Viral Hepatitis Group. Genotype distribution of hepatitis C virus in the Hungarian population with chronic viral hepatitis C. Eur J Gatsroenterol Hepatol 2003; 15: 449-450. (Pubitemid 36521049)
30. Andonov A, Teoharov P, Bakalova S. Predominance of hepatitis C virus genotype 1b in Bulgaria. European J Clin Microbiol Infect Dis 1996; 15: 521-523. (Pubitemid 26241710)
31. Andrejczyn M, Wasylieva N, Gospodarski I. Some aspects of epidemiology of HCV infections in Ukraine. Przegl Epidemiol 2005; 59: 499-501.
32. Cochrane A, Searle B, Hardie A, et al. A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis 2002; 186: 1212-1221. (Pubitemid 35192999)
33. Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 2004; 85: 3173-3188. (Pubitemid 39445434)
34. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol 2003; 20: 381-387. (Pubitemid 36427172)
35. Cantaloube JF, Gallian P, Attoui H, Biagini P, De Micco P, de Lamballerie X. Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France. J Clin Microbiol 2005; 43: 3624-3629. (Pubitemid 41129638)